Benlysta
Benlysta to be fast-tracked by FDA
August 20, 2010Sales and Marketing Benlysta, GSK, HGS, Lupus
New lupus drug Benlysta has been given priority review status by the FDA.Benlysta (belimumab) has been developed by Human Genome …
UCB’s new lupus treatment promising
June 17, 2010Research and Development Benlysta, Lupus, UCB, epratuzumab
A new monoclonal antibody treatment for lupus has shown promise in phase II trials, according to UCB. The biopharmaceutical company …
EU regulators to assess potential lupus breakthrough drug
June 8, 2010Sales and Marketing Benlysta, Human Genome Sciences, Lupus
GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …
Phase III success for GSK’s lupus drug
November 3, 2009Research and Development, Sales and Marketing Benlysta, GSK
GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …
Lupus drug shows surprise phase III success
July 23, 2009Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus
GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
